With expansion a prime focus for businesses worldwide, many are looking towards rapidly establishing new regions of growth, particularly in Asia, Pacifi c Rim countries.
The latest business developments from across Asia by Heather Hobbs To appear in our next issue, send your Business and Financial News stories to
heather@intlabmate.com
This section of International Labmate will especially look at the success of both Asian and European companies with established premises or business partnerships, highlighting the opportunities that exist while realising potential for other companies to move into export markets.
Registrations for analytica Vietnam 2021 are Now Open
exhibitors and visitors quickly found the right business contacts. In 2021, the organiser will again organise these free 20-minute meetings. China, Germany, Singapore and Taiwan, among others, will be represented at the trade fair with national pavilions. In addition, increased numbers of visitor delegations from neighbouring countries such as Cambodia and Laos are expected.
From 14 to 16 April 2021, analytica Vietnam opens its doors for the seventh time at the Saigon Exhibition & Convention Center in Ho Chi Minh City. The trade fair for laboratory technology, analysis, biotechnology and diagnostics is a spin-off of the world’s leading trade fair analytica in Munich. Since its launch in 2009, analytica Vietnam has developed into one of the most important platforms for the industry in Southeast Asia. The exhibition is going to be accompanied by an extensive conference and supporting program that focuses on the exchange of specialist knowledge. Exhibitors Registrations for analytica Vietnam 2021 are now open.
Previous events have shown how attractive the Vietnamese market is for the international analysis, biotechnology and laboratory technology sector: in 2019, the trade fair grew to a record level in terms of exhibitors, visitors and exhibition space. 143 exhibitors from 15 countries occupied around 33% more space than in 2017, with 4,144 visitors from the fi eld attending. In 268 buyer-seller meetings,
The comprehensive supporting program focuses entirely on the exchange of expertise. An important component is the analytica Vietnam conference. There, national and international experts will give lectures on the latest developments in the fi elds of biotechnology, pharmaceuticals, food and environmental analysis. Additionally, there will also be practice-oriented workshops, an Exhibitor Forum and live shows on safety in the laboratory. One day before the start of the trade fair, exhibitors will have the opportunity to gain an insight into selected laboratories on site in the course of a lab tour.
“With analytica Vietnam, biannually we bring together top-class international exhibitors, leading industry experts and several thousand visitors from the fi eld. The event has earned itself an excellent reputation in the industry,” said Gabriele Kraus, Executive Director of the trade fair organiser IMAG. Susanne Grödl, Exhibition Director at the analytica events, added: “In doing so, we want not only to create a platform to present the latest technologies and services in the industry, but also to promote a comprehensive exchange of expert knowledge. For this know-how continues to be in great demand in Vietnam.”
More information:
ilmt.co/PL/KoLa 52290pr@reply-direct.com
Nanion Technologies and Nexel Partner to Open a New Reference Demonstration Laboratory in South Korea
Dr Choong-Seong Han, CEO of Nexel. © Nanion Technologies GmbH
Nanion Technologies and Nexel are pleased to announce a partnership, focused on combining Nanion’s CardioExcyte 96 and FLEXcyte 96 cell monitoring technology with Nexel’s hiPSC-derived cells for demonstration purposes. Bringing together the two companies’ infrastructure and expertise serves to meet the growing demand for a reliable, high throughput cell monitoring technology in Asia.
New Aquatec Distributor Agreement for Japan Announced
Aquatec is delighted to welcome SeaBreath as a representative for the distribution of their established underwater instrumentation for oceanographic research, environmental and coastal applications in the highly sought-after Japanese market.
SeaBreath is a group of subsea specialists which provides comprehensive proposals for observations, surveys and research. The company caters to the needs of the Ocean Science, Hydrography, Coastal Engineering, Fisheries Science, Marine Biology, and Underwater Robotics markets.
The newly signed representatives will provide sales support for Aquatec’s innovative AQUAscat® range of acoustic suspended sediment profi lers, as well as the AQUAlogger® instrument line of turbidity, temperature and depth loggers.
Managing Director of Aquatec Group, Andy Smerdon, said: “We are looking forward to working closely with SeaBreath in order to provide customers in Japan the very best service and innovative technologies. Aquatec has been designing instrumentation for oceanographic and environmental monitoring for 30 years, and we are continuously improving and developing our instruments to meet our customers’ needs.”
52362pr@reply-direct.com
The Nanion- Nexel partnership brings together profound skills in comprehensive in vitro electrophysiology technology and development of human induced pluripotent stem cells (hiPSCs), with focus on cardiomyocytes. Under the partnership, Nexel opens a reference demonstration laboratory for Nanion´s systems at Nexel’s headquarters in Seoul, whereby both companies aim to signifi cantly upscale support of their clients in Asia.
Dr Choong-Seong Han, CEO of Nexel, said: “Nexel is proud to start this partnership with Nanion Technologies. We believe it will further build on the excellent relationship we have developed together in the last year. The Cardiosight®-S cardiomyocytes have been fully validated on the CardioExcyte 96 and FLEXcyte 96 systems and our expert scientists are dedicated to provide the best demo settings as well as product experience for customers, as part of the collaboration. We hope interest in both Nanion’s and Nexel’s offerings will increase with our collaborative efforts.”
Alliance Boosts Drug Discovery Service
Dijon-based biopharmaceutical company Oncodesign has formed a new strategic alliance with Chinese biotech HitGen, enabling the combined complementary technology of both partners to more effi ciently identify novel hits for challenging biological targets. The French company’s Integrated Drug Discovery Service (IDDS) offer, known as DRIVE™ has also been strengthened and deepened through the collaboration.
The two companies have built a joint value proposition where HitGen applies its powerful DNA Encoded Library (DEL) technology platform to identify tractable hits and Oncodesign’s DRIVE can quickly assess newly synthesised compounds within a collaborative environment between medicinal chemists, in vitro/in vivo pharmacologists and DMPK specialists.
52469pr@reply-direct.com
Frank Henrichsen, Director of Global Sales of Nanion Technologies added: “We are very eager to strengthen our position in the Asian market and especially in Korea. In Nexel, we see a valuable partner to help us develop our presence, in this case through opening their laboratories and enabling the use Nanion´s technology for demo purposes at their premises. Combining Nexel´s hiPSC- derived cardiomyocytes and cardiac in vitro assays with Nanion’s CardioExcyte 96 and FLEXcyte 96 systems, we are confi dent that our customers will get an excellent package solution for use in safety pharmacology and toxicology assays. We are also very happy that Nexel has already implemented the systems into their quality control procedure of Cardiosight®-S cardiomyocytes.”
52361pr@reply-direct.com
Business
Opportunities Asia
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
